Huamao Mark Lin (Huamao M Lin)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Topics

Palliative Care

Chronic Myeloid Leukemia

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Journal of medical economics

Current medical research and opinion

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Karen L Reckamp, Huamao Mark Lin, Holly L Cranmer, Yanyu Wu, Pingkuan Zhang, Stephen Kay, Laura J Walton, Junwu Shen, Sanjay Popat, D Ross Camidge
Overall survival indirect treatment comparison between brigatinib and alectinib for the treatment of front-line anaplastic lymphoma kinase-positive non-small cell lung cancer using data from ALEX and final results from ALTA-1L. Current medical research and opinion 38 (9) (2022)
Karen L Reckamp, Huamao Mark Lin, Holly L Cranmer, Yanyu Wu, Pingkuan Zhang, Laura J Walton, Stephen Kay, Allie Cichewicz, Binod Neupane, Kyle Fahrbach, Sanjay Popat, D Ross Camidge
Indirect comparisons of brigatinib and alectinib for front-line ALK -positive non-small-cell lung cancer. Future oncology (London, England) 18 (20) (2022)
Christina Soeun Kwon, Huamao Mark Lin, Victoria Crossland, Eric N Churchill, Eileen Curran, Anna Forsythe, Dimitrios Tomaras, Sai-Hong Ignatius Ou
Non-small cell lung cancer with EGFR exon 20 insertion mutation: a systematic literature review and meta-analysis of patient outcomes. Current medical research and opinion 38 (8) (2022)
Huamao Mark Lin, Xiaoyun Pan, Peijie Hou, Hui Huang, Yanyu Wu, Kaili Ren, Mohammad Jahanzeb
Economic burden in patients with ALK + non-small cell lung cancer, with or without brain metastases, receiving second-line anaplastic lymphoma kinase (ALK) inhibitors. Journal of medical economics 23 (8) (2020)
Ariane K Kawata, William R Lenderking, Olabimpe R Eseyin, David Kerstein, Joice Huang, Hui Huang, Pingkuan Zhang, Huamao Mark Lin
Converting EORTC QLQ-C30 scores to utility scores in the brigatinib ALTA study. Journal of medical economics 22 (9) (2019)
Parameswaran Hari, Huamao Mark Lin, Carl V Asche, Jinma Ren, Candice Yong, Katarina Luptakova, Douglas V Faller, Vaishali Sanchorawala
Treatment patterns and health care resource utilization among patients with relapsed/refractory systemic light chain amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 25 (1) (2018)